PMID- 23640575 OWN - NLM STAT- MEDLINE DCOM- 20131105 LR - 20211021 IS - 1573-7209 (Electronic) IS - 0969-6970 (Print) IS - 0969-6970 (Linking) VI - 16 IP - 3 DP - 2013 Jul TI - Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis. PG - 723-34 LID - 10.1007/s10456-013-9349-6 [doi] AB - The recruitment of mural cells such as pericytes to patent vessels with an endothelial lumen is a key factor for the maturation of blood vessels and the prevention of hemorrhage in pathological angiogenesis. To date, our understanding of the specific trigger underlying the transition from cell growth to the maturation phase remains incomplete. Since rapid endothelial cell growth causes pericyte loss, we hypothesized that suppression of endothelial growth factors would both promote pericyte recruitment, in addition to inhibiting pathological angiogenesis. Here, we demonstrate that targeted knockdown of apelin in endothelial cells using siRNA induced the expression of monocyte chemoattractant protein-1 (MCP-1) through activation of Smad3, via suppression of the PI3K/Akt pathway. The conditioned medium of endothelial cells treated with apelin siRNA enhanced the migration of vascular smooth muscle cells, through MCP-1 and its receptor pathway. Moreover, in vivo delivery of siRNA targeting apelin, which causes exuberant endothelial cell proliferation and pathological angiogenesis through its receptor APJ, led to increased pericyte coverage and suppressed pathological angiogenesis in an oxygen-induced retinopathy model. These data demonstrate that apelin is not only a potent endothelial growth factor, but also restricts pericyte recruitment, establishing a new connection between endothelial cell proliferation signaling and a trigger of mural recruitment. FAU - Kasai, Atsushi AU - Kasai A AD - Interdisciplinary Program for Biomedical Sciences, Institute for Academic Initiatives, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. kasai@phs.osaka-u.ac.jp FAU - Ishimaru, Yuki AU - Ishimaru Y FAU - Higashino, Kosuke AU - Higashino K FAU - Kobayashi, Kohei AU - Kobayashi K FAU - Yamamuro, Akiko AU - Yamamuro A FAU - Yoshioka, Yasuhiro AU - Yoshioka Y FAU - Maeda, Sadaaki AU - Maeda S LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20130503 PL - Germany TA - Angiogenesis JT - Angiogenesis JID - 9814575 RN - 0 (Adipokines) RN - 0 (Apelin) RN - 0 (Apelin Receptors) RN - 0 (Apln protein, mouse) RN - 0 (Aplnr protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Culture Media, Conditioned) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (RNA, Small Interfering) RN - 0 (Receptors, G-Protein-Coupled) RN - 0 (Smad3 Protein) RN - 0 (Smad3 protein, mouse) SB - IM MH - Adipokines MH - Analysis of Variance MH - Animals MH - Apelin MH - Apelin Receptors MH - Blotting, Western MH - Chemokine CCL2/*metabolism MH - Culture Media, Conditioned/pharmacology MH - Endothelial Cells/*cytology/metabolism MH - Gene Knockdown Techniques MH - Immunohistochemistry MH - Intercellular Signaling Peptides and Proteins/genetics/*metabolism MH - Mice MH - Muscle, Smooth, Vascular/metabolism MH - Neovascularization, Pathologic/*physiopathology MH - RNA, Small Interfering/pharmacology MH - Real-Time Polymerase Chain Reaction MH - Receptors, G-Protein-Coupled/metabolism MH - Retinal Vessels/*physiopathology MH - Reverse Transcriptase Polymerase Chain Reaction MH - Smad3 Protein/metabolism MH - Tumor Cells, Cultured PMC - PMC3682100 EDAT- 2013/05/04 06:00 MHDA- 2013/11/06 06:00 PMCR- 2013/05/03 CRDT- 2013/05/04 06:00 PHST- 2012/12/13 00:00 [received] PHST- 2013/04/24 00:00 [accepted] PHST- 2013/05/04 06:00 [entrez] PHST- 2013/05/04 06:00 [pubmed] PHST- 2013/11/06 06:00 [medline] PHST- 2013/05/03 00:00 [pmc-release] AID - 9349 [pii] AID - 10.1007/s10456-013-9349-6 [doi] PST - ppublish SO - Angiogenesis. 2013 Jul;16(3):723-34. doi: 10.1007/s10456-013-9349-6. Epub 2013 May 3.